ANALYTICAL DEVELOPMENT AND VALIDATION OF A LC-MS METHOD FOR ESTIMATION OF N-NITROSO DICLOFENAC IN DICLOFENAC SODIUM GEL 3%

Main Article Content

Abhas Pandey
Ashish Jain
Mukesh Patil
Gauri Patil

Keywords

N-Nitroso Diclofenac Impurity, Diclofenac Sodium, LC-MS, ICH, Validation

Abstract

A new liquid chromatography-mass spectrometry (LC-MS) method that is selective and sensitive was developed and validated for the identification and quantification of N-Nitroso Diclofenac Impurity in Diclofenac Sodium Gel by LC-MS. The method is specific, accurate and precise. Chromatographic separation was accomplished on a symmetry C18 column 250x4.6mm, 5µ, using gradient type of separation. In which two different composition of mobile phase were used i.e. Mobile Phase A is a mixture of buffer (ammonium formate and formic acid) and acetonitrile (75:25) whereas Mobile Phase B is Acetonitrile (100%) with run time of 35 minutes. Linearity range of 0.000048 to 0.010055 µg/mL and 0.06 to 12.57 µg/mL (concentration with respect to sample). The standard solution of N-Nitroso Diclofenac is stable up to 44 hours and sample solution of Diclofenac Sodium Gel 3% is stable for 35 minutes. The method is validated according to ICH Q2 (R1).

Abstract 54 | pdf Downloads 19

References

1. Vasilios A. Skoutakis, Charles A. Carter, Daniel E. Petty, Review of Diclofenac and Evaluation of its Place in Therapy as Non-Steroidal Anti-Inflammatory Agent, Sage Journals, 1988 Nov, 22(11).
2. Dr. Rahul Kumar, Rahul Dev, Kunwar Sanjeev Singh, Dr. Anil Tyagi, Hari Darshan Singh, Harendra Singh, Vikash Mohniya, Manish Chouhan, Quantitative Evaluation of N-Nitrosamine Impurities in Telmisartan Tablets USP 20MG, 40MG and 80MG by Gas Chromatography Coupled with Mass Spectrometer, Indo American Journal of Pharmaceutical Sciences, 2022 Aug, 9(8), 77-93.
3. V. K. Deshmukh, V. B. Ghawate, et al, A Review on Nitrosamine Impurities Present in Drugs, Pharmaceutical Resonance 2022. 4(2). 44-48.
4. European Medicines Agency, “EMA advises companies on steps to Take to avoid nitrosamines in human Medicines”, 2019 Sep.